Aktis Oncology Shares Surge Over 5% on First Trading Day
With the first biotech IPO of the year, Aktis Oncology blew past expectations, with shares jumping on the first day of trading.LATEST IPOS AND DIRECT LISTINGS:Aktis Oncologyopened on January 9 at $27. The clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large patient populations priced its upsized initial public offering of 17.65M shares of its common stock at a price to the public of $18.00 per share. The deal priced at the high-end of the $16.00-$18.00 range.Buda Juiceopened on January 8 at $12. The company priced its initial public offering of 2,666,667 shares of its common stock at the public offering price of $7.50 per share. The deal priced at the low end of its $7.50-$9.00 range. Buda Juice intends to use the net proceeds from the offering to develop and build production plants in South Carolina and Arizona/Nevada, expand capacity in its Dallas production plant, support in-store marketing and provide working capital for its expansion of its freshly crafted juices, lemonades, and wellness shots to grocery retailers.RECENT SPAC IPOS:Lafayette Digital Acquisition Iopened on January 9 at $10.01. The blank check company had priced its initial public offering of 25M units at an offering price of $10.00 per unit, with each unit consisting of one Class A ordinary share and one-fourth of one redeemable warrant. Each whole warrant, which becomes exercisable 30 days after the completion of the company's initial business combination, will entitle the holder thereof to purchase one Class A ordinary share at $11.50 per share, subject to adjustments.Bleichroeder Acquisition IIopened on Jnauary 8 at $10.03. The blank check company may pursue an acquisition opportunity in any industry, sector or geographic region. The company's primary focus, however, will be on North American and European businesses in disruptive growth sectors, which may include companies within sectors that are being transformed via technology adoption.Soren Acquisitionopened on January 7 at $10. The blank check company may pursue an acquisition opportunity in any business or industry or at any stage of its corporate evolution, but is focused on completing a business combination with "an attractive target business within the healthcare industry".Black Spade Acquisition IIIopened on January 6 at $9.97. The special purpose acquisition company is sponsored by an affiliate of Black Spade Capital Limited.PERFORMANCE:Prices as of 11 am ET on Monday, January 12 -Aktis Oncology – up over 5% at $23.53;Buda Juice – up almost 2% at $8.31.RECENT IPOS TO WATCH:Medlineand Andersen Groupare already seeing coverage roll out, while Starfighters Spaceis among stocks that could see new coverage this week as the quiet periods for banks that underwrote the companies' IPOs expire.UPCOMING IPOS:Upcoming IPO and direct listings expected include PicS N.V., Grayscale, Klook, Speed Group, and Lendbuzz.Clickto see upcoming IPO calendar on TipRanks.PicS N.V.filed for an initial public offering of Class A common shares, which it intends to apply to list on the Nasdaq Global Select Market under the symbol "PICS." The company said it will not seek a listing for its Class B common shares on Nasdaq or on any other exchange. The filing stated, "PicPay Netherlands, the company whose Class A common shares are being offered in this prospectus, was incorporated on December 27, 2023, as a private limited liability company under Dutch law, with its corporate seat in Amsterdam, the Netherlands, with the name 'Picpay Holdings Netherlands B.V.' Prior to the closing of this offering, the issuer will be converted into a public limited liability company under Dutch law with the name 'PicS N.V.'... At PicPay, we believe financial services should be mobile, frictionless, and instantaneous. Our mission is to empower consumers and businesses across Brazil with innovative solutions to redefine the way people manage their traditional daily finances. We break down the barriers to traditional financial services and are driven by a vision of a future where financial services are accessible for all. We are committed to simplifying financial transactions, fostering economic inclusion and providing the tools and resources for people to achieve their financial goals."GrayscaleInvestments filed a prospectus for an initial public offering on the New York Stock Exchange under the ticker symbol "GRAY." Grayscale says it is the largest digital asset-focused investment platform in the world, with $35B in assets under management as of September 30. "Our mission is to make digital asset investing simple and open to every investor. Founded in 2013, we have pioneered regulated access to the digital asset class. Our platform spans the full spectrum of institutional-grade solutions, providing investors with the broadest and most diverse suite of digital asset-focused investment products in the United States based on number of products," the company added.Klook Technology, which identifies itself as "the largest pan-regional experiences platform in Asia-Pacific" by gross transaction volume in 2024, announced that it has filed a registration statement on Form F-1 with the U.S. Securities and Exchange Commission relating to the proposed initial public offering of American Depositary Shares representing its ordinary shares. The company has applied to list the ADSs on the New York Stock Exchange under the ticker symbol "KLK". The number of ADSs to be offered and the price range for the proposed offering have not yet been determined.Speed Groupfiled a prospectus for 2.5M share initial public offering. It expects the IPO price to be in the range of $4.00 to $5.00 per. The company's operating subsidiary, Speed Logistics, is an e-commerce logistics provider providing end-to-end logistics solution in Hong Kong, Europe and North America. The services include warehousing, customs clearance, air transportation, and final delivery from the European airports. For the years ended June 30, 2024 and 2025, Speed's revenues were $17.9M and $22.64M, respectively.Lendbuzz Inc.is offering an undetermined number of shares of its common stock and the selling stockholders identified in this prospectus are offering additional shares of common stock, according to an initial public offering prospectus filed with the SEC. The company has applied to list its common stock on the Nasdaq Global Select Market under the symbol "LBZZ." The prospectus states: "Our mission is to offer fair access to credit for underserved populations. We are a financial technology company that utilizes artificial intelligence, or AI, and machine learning algorithms to better assess consumer credit risk and expand access to credit. We seamlessly process large sets of data through advanced computational approaches to more accurately predict a consumer's creditworthiness. Our business benefits both consumers through expanded access to credit, and auto dealerships via increased vehicle sales."OTHER IPO NEWS:Construction equipment rental firm EquipmentShare.com, which filed publicly for a listing on December 9, may begin formal marketing for its initial public offering as soon as next week and could raise about $1B, a person familiar with the matter told Bloomberg's Bailey Lipschultz and Anthony Hughes. Motive Technologies, which makes artificial intelligence-enabled fleet management software and filed its IPO paperwork publicly on December 23, may also begin formal marketing next week as it seeks to raise around $600M, the report noted that a person with knowledge of the deal said."Opening Day" is The Fly's recurring series of stories on the latest initial public offerings, their performance, and upcoming IPOs.
Trade with 70% Backtested Accuracy
Analyst Views on MDLN
About MDLN
About the author

Jennifer Garner's Characters: Garner is known for her roles as Sidney Bristow in Alias and Elektra in Marvel films, where she faced tough adversaries.
Current Challenge: The actress is now dealing with the challenges posed by unpredictable investors in her entrepreneurial ventures.
Entrepreneurial Success: Despite the challenges, Garner appears to be successfully navigating the investment landscape.
Transition from Acting to Business: Garner's shift from acting to entrepreneurship highlights her versatility and determination in facing new challenges.
Amazon's Spending Forecast: Amazon's recent spending forecast has surprised the markets, contrasting sharply with the prevailing risk-averse sentiment among investors.
Concerns Over AI Investments: This situation raises concerns about whether the current enthusiasm for artificial intelligence investments may mirror the speculative excesses seen during the dot-com bubble.

Upcoming IPOs: Three new IPOs are set to launch today, attracting investor attention.
Key Players: The companies involved in these IPOs include SpaceX, OpenAI, and Anthropic.
Market Anticipation: Investors are particularly eager for these IPOs as they await significant developments later this year.
Investment Climate: The current market environment is buzzing with excitement over these high-profile companies entering the public market.
- Revenue and Profit Growth: Symbotic reported a 26% revenue increase and a 72% rise in gross profit for fiscal year 2025, indicating significant progress towards profitability, which is likely to attract more investor interest.
- Strong Financial Position: By the end of 2025, Symbotic's cash reserves reached $1.3 billion, with a backlog of $22.5 billion, nearly ten times its 2025 revenue, showcasing robust potential for future growth.
- Customer Base Expansion: The signing of a new customer agreement with medical supplies giant Medline signifies the successful application of Symbotic's AI automation technology across industries, enhancing its market competitiveness.
- Strategic Acquisitions and Partnerships: Symbotic's acquisition of Walmart's advanced systems and robotics business, along with a nearly $11 billion contract for its Exol project with SoftBank, is expected to drive sustained growth for the company in the coming years.
- Significant Performance Growth: Symbotic achieved a remarkable 150.9% stock price increase in 2025, with a 26% revenue rise and a 72% gross profit surge, indicating substantial progress towards profitability and setting the stage for continued momentum in 2026.
- Massive Backlog: As of 2025, Symbotic's backlog reached $22.5 billion, nearly ten times its revenue for the year, providing robust support for future revenue growth and reflecting strong market demand for its automation solutions.
- Customer Base Expansion: The signing of a new agreement with medical supplies giant Medline marks a successful diversification of Symbotic's business beyond retail, demonstrating the scalability of its AI-powered automation technology across different industries.
- Strategic Acquisitions and Partnerships: Symbotic's acquisition of Walmart's advanced systems and robotics business, along with the launch of the nearly $11 billion warehouse-as-a-service project Exol in partnership with SoftBank, are poised to drive significant growth for the company in the future.
- IPO Financing Scale: Medline's IPO successfully raised $6.3 billion at a price of $29 per share, significantly enhancing the company's capital structure, with plans to use the proceeds to pay down $16.5 billion in debt, thereby improving financial health.
- Sales Growth Momentum: Since its founding in 1966, Medline has achieved an average annual sales growth of 18%, with projections indicating sales will reach $30 billion by 2026, demonstrating strong growth potential in the medical supply market, particularly given the resilience of healthcare demand amid economic uncertainties.
- Market Competitive Advantage: With 335,000 products and 33 manufacturing facilities, Medline offers next-day delivery to 95% of U.S. customers, leveraging its private label products to enhance margins and solidify its leadership position in the medical product supply chain.
- Superior Financial Performance: Medline boasts a gross margin of approximately 27.4%, significantly higher than key competitors, and is projected to generate $1.5 billion in free cash flow in 2025, showcasing its profitability and cash flow generation capabilities, further enhancing its investment appeal.










